Target intelligence / Profile preview

Ribosomal protein S26 pseudogene 4 (RPS26P4)

Target: RPS26P4
Molecular classification: Other

Overview

Ribosomal protein S26 pseudogene 4 is a processed pseudogene corresponding to the ribosomal protein S26 (RPS26) gene. Pseudogenes are non-functional copies of genes; they typically arise from genomic duplication or retrotransposition events and do not encode active proteins. RPS26P4 does not contribute to ribosome structure or function, nor is it implicated in human disease or pharmacology. While the study of ribosomal protein pseudogenes is valuable for understanding genome evolution, they are not considered drug targets and do not have defined biological or pharmacological functions.

Other names: RPS26_32_1733RPS26P4

Beyond the preview

Go deeper on Ribosomal protein S26 pseudogene 4 (RPS26P4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein S26 pseudogene 4 (RPS26P4).

Explore the full profile